Top Cardiovascular metabolic system diseases

Cardiovascular metabolic system diseases have become a global health crisis, affecting the quality of life and health status of people.

 

Cardiovascular Diseases are a group of disorders of the heart and blood vessels, which are the leading cause of death globally. An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Youngen provides professional heart disease treatment as one of the leading biomedical companies.

 

The umbrella term “metabolic diseases” includes hypertension, type 2 diabetes mellitus, hyperlipidemia , obesity, and non-alcoholic fatty liver disease, which is drawing increasing awareness. Many of these diseases occur together, share common risk factors, and are associated with increased risks of disability, cancer, and premature deaths.

 

We can provide professional heart problem solution for clients, anything you need, please contact us.

 

If you want to know more about cardiovascular pharmacotherapy, heart disorder treatment and metabolic treatment, please visit our website.

 

Enjoyed this article? Stay informed by joining our newsletter!

Comments

You must be logged in to post a comment.

About Author

Youngen, based in Beijing, is a biotechnology company pioneering the development of next-generation siRNA drugs to silence specific mRNAs and reduce the production of proteins that cause disease. Youngen has been dedicating to bring RNAi therapeutics to a broad spectrum of difficult-to-treat diseases, both rare and general population impacting millions of people around the world. Leveraging these platform technologies, we built diversified product pipelines with globally competitive, first-in-class and best-in-class potential. We’re exploring many therapeutic areas to bring more treatment options to the patients with metabolic and cardiovascular diseases, immune-mediated diseases, and neurological disorders. https://www.youngenbiomed.com/